This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banerjee, B.
Right arrow Articles by Kurup, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerjee, B.
Right arrow Articles by Kurup, V. P.

 Previous Article  |  Next Article 

Infection and Immunity, October 2004, p. 6087-6094, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6087-6094.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Modulation of Airway Inflammation by Immunostimulatory CpG Oligodeoxynucleotides in a Murine Model of Allergic Aspergillosis

Banani Banerjee,1* Kevin J. Kelly,1 Jordan N. Fink,1 James D. Henderson Jr.,2,3 Naveen K. Bansal,4 and Viswanath P. Kurup1,3

Allergy-Immunology Division, Department of Pediatrics,1 Department of Surgery Medical College of Wisconsin,2 Research Service, VA Medical Center,3 Department of Mathematics, Marquette University, Milwaukee, Wisconsin4

Received 19 December 2003/ Returned for modification 19 January 2004/ Accepted 16 June 2004

Allergic aspergillosis is a Th2 T-lymphocyte-mediated pulmonary complication in patients with atopic asthma and cystic fibrosis. Therefore, any therapeutic strategy that selectively inhibits Th2 T-cell activation may be useful in downregulating allergic lung inflammation in asthma. In the present study, we developed a CpG oligodeoxynucleotide (ODN)-based immune intervention of allergic inflammation in a mouse model of allergic aspergillosis. Four different groups of mice were used in a short-term immunization protocol. Three experimental groups of animals (groups 1 to 3) were sensitized with Aspergillus fumigatus antigens. Animals in group 1 were immunized with A. fumigatus antigen alone, while those in group 2 were treated with CpG-ODN 1 day before the first antigen immunization, and the animals in group 3 received the first CpG-ODN administration between the antigen treatments. The animals in group 4 served as controls and were given phosphate-buffered saline. Allergen-specific serum immunoglobulins and total immunoglobulin E in different groups of animals were measured by enzyme-linked immunosorbent assay, while airway remodeling and cytokine production were studied by immunohistochemistry. The results demonstrated that CpG-ODN administration either before (group 2) or between (group 3) antigen treatments resulted in reduced total immunoglobulin E levels and peripheral blood eosinophil numbers compared to A. fumigatus allergen-sensitized group 1 animals. Similarly, treatment with CpG-ODN also downregulated inflammatory cell infiltration, goblet cell hyperplasia, and basement membrane thickening compared to A. fumigatus-sensitized mice. The distinct reduction in peripheral blood eosinophilia and airway remodeling in CpG-ODN-treated mice emphasized its usefulness as an immunomodulating agent for allergic fungal diseases.


* Corresponding author. Mailing address: VA Medical Center, Research Service 151-I, 5000 West National Ave., Milwaukee, WI 53295. Phone: (414) 384-2000, ext. 41510. Fax: (414) 382-5374. E-mail: banerjee{at}mcw.edu.

Editor: T. R. Kozel


Infection and Immunity, October 2004, p. 6087-6094, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6087-6094.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kline, J. N. (2007). Eat Dirt: CpG DNA and Immunomodulation of Asthma. Proc Am Thorac Soc 4: 283-288 [Abstract] [Full Text]  
  • Tao, J., Segal, B. H., Eppolito, C., Li, Q., Dennis, C. G., Youn, R., Shrikant, P. A. (2006). Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity. J. Leukoc. Biol. 80: 529-537 [Abstract] [Full Text]  
  • Iwashita, H., Morita, S., Sagiya, Y., Nakanishi, A. (2006). Role of Eosinophil Chemotactic Factor by T Lymphocytes on Airway Hyperresponsiveness in a Murine Model of Allergic Asthma. Am. J. Respir. Cell Mol. Bio. 35: 103-109 [Abstract] [Full Text]  
  • Montagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P., Romani, L. (2006). Immunity and Tolerance to Aspergillus Involve Functionally Distinct Regulatory T Cells and Tryptophan Catabolism. J. Immunol. 176: 1712-1723 [Abstract] [Full Text]  
  • Velasco, G., Campo, M., Manrique, O. J., Bellou, A., He, H., Arestides, R. S. S., Schaub, B., Perkins, D. L., Finn, P. W. (2005). Toll-Like Receptor 4 or 2 Agonists Decrease Allergic Inflammation. Am. J. Respir. Cell Mol. Bio. 32: 218-224 [Abstract] [Full Text]